Exploring the biology of 'double positive' T cells

byLudwig Cancer ResearchCredit: CC0 Public DomainThe molecular markers CD4 and CD8—defining helper T cells and killer T cells, respectively—were once considered mutually exclusive. But "dou

Updated on: January 07,2024

Exploring the biology of 'double positive' T cells

byLudwig Cancer ResearchCredit: CC0 Public DomainThe molecular markers CD4 and CD8—defining helper T cells and killer T cells, respectively—were once considered mutually exclusive. But "dou

Updated on:January 07,2024

Discovery could lead to 'kinder' treatment for childhood neuroblastoma

by University of CambridgeA ball of neuroblastoma cells forming mature nerves after drug treatment. Credit: Kirsty Ferguson/Developmental CellChildren with neuroblastoma—responsible for 15% of ca

Updated on: March 23,2024

Discovery could lead to 'kinder' treatment for childhood neuroblastoma

by University of CambridgeA ball of neuroblastoma cells forming mature nerves after drug treatment. Credit: Kirsty Ferguson/Developmental CellChildren with neuroblastoma—responsible for 15% of ca

Updated on:March 23,2024

Here's why some high-risk patients aren't getting drugs to combat COVID

by Emily Alpert Reyes, Los Angeles TimesCredit: Unsplash/CC0 Public DomainAs the toll from the COVID-19 pandemic continued to mount, antiviral medications such as Paxlovid were hailed by health offici

Updated on: May 26,2024

Here's why some high-risk patients aren't getting drugs to combat COVID

by Emily Alpert Reyes, Los Angeles TimesCredit: Unsplash/CC0 Public DomainAs the toll from the COVID-19 pandemic continued to mount, antiviral medications such as Paxlovid were hailed by health offici

Updated on:May 26,2024

Major pathologic response to neoadjuvant pembrolizumab in advanced melanoma trial exceeds 50%

by SWOG Cancer Research NetworkCredit: CC0 Public DomainIn exploratory analyses of results from the SWOG S1801 trial in patients with stage III-IV resectable melanoma, researchers saw a major patholog

Updated on: April 22,2024

Major pathologic response to neoadjuvant pembrolizumab in advanced melanoma trial exceeds 50%

by SWOG Cancer Research NetworkCredit: CC0 Public DomainIn exploratory analyses of results from the SWOG S1801 trial in patients with stage III-IV resectable melanoma, researchers saw a major patholog

Updated on:April 22,2024

Researchers develop new method to detect cancerous DNA in lung cancer patients' blood

by European Society for Medical OncologyLung CA seen on CXR. Credit:CC BY-SA 4.0James Heilman, MD/WikipediaA new method of determining the sequence of molecules in DNA can be used to

Updated on: June 11,2024

Researchers develop new method to detect cancerous DNA in lung cancer patients' blood

by European Society for Medical OncologyLung CA seen on CXR. Credit:CC BY-SA 4.0James Heilman, MD/WikipediaA new method of determining the sequence of molecules in DNA can be used to

Updated on:June 11,2024

Cancer cells adopt hitherto unknown state to facilitate metastasis

by Susann Huster,Leipzig UniversityCredit: Pixabay/CC0 Public DomainThe ancient Egyptians, as described in the Ebers Papyrus, already knew that palpation—feeling for hardened lumps—can help diag

Updated on: December 18,2023

Cancer cells adopt hitherto unknown state to facilitate metastasis

by Susann Huster,Leipzig UniversityCredit: Pixabay/CC0 Public DomainThe ancient Egyptians, as described in the Ebers Papyrus, already knew that palpation—feeling for hardened lumps—can help diag

Updated on:December 18,2023

Allergy medicine may help treat lung cancer, research suggests

byThe Mount Sinai HospitalChest scans showing lung tumors in a patient with metastatic non-small cell lung cancer prior to and after receiving dupilumab with conventional immunotherapy. Credit:

Updated on: January 25,2024

Allergy medicine may help treat lung cancer, research suggests

byThe Mount Sinai HospitalChest scans showing lung tumors in a patient with metastatic non-small cell lung cancer prior to and after receiving dupilumab with conventional immunotherapy. Credit:

Updated on:January 25,2024

Long-term pancreatic cancer survivors report excellent post-surgery quality of life

by Chloe Corey,Mayo ClinicCredit: Mayo Clinic News NetworkPancreatic cancer is considered the most lethal cancer in the human body. But new treatment advances are improving outcomes for patients

Updated on: February 18,2024

Long-term pancreatic cancer survivors report excellent post-surgery quality of life

by Chloe Corey,Mayo ClinicCredit: Mayo Clinic News NetworkPancreatic cancer is considered the most lethal cancer in the human body. But new treatment advances are improving outcomes for patients

Updated on:February 18,2024

Identification of colony stimulating factor 1 receptor offers new strategy for cancer immunotherapy

by Zhang Nannan,Chinese Academy of SciencesIHMT-CSF1R-833 alters the macrophage polarization in M2 macrophages derived from RAW264.7 cells by inducing the M1 macrophage phenotype. Credit: Liang

Updated on: December 25,2023

Identification of colony stimulating factor 1 receptor offers new strategy for cancer immunotherapy

by Zhang Nannan,Chinese Academy of SciencesIHMT-CSF1R-833 alters the macrophage polarization in M2 macrophages derived from RAW264.7 cells by inducing the M1 macrophage phenotype. Credit: Liang

Updated on:December 25,2023

Researchers uncover on/off switch for breast cancer metastasis

by Rebecca McClellan,Stanford UniversitySongnan Wang (left) and Lingyin Li (right) found that a protein called ENPP1 acts as an on/off switch for breast cancer metastases. High protein levels le

Updated on: December 28,2023

Researchers uncover on/off switch for breast cancer metastasis

by Rebecca McClellan,Stanford UniversitySongnan Wang (left) and Lingyin Li (right) found that a protein called ENPP1 acts as an on/off switch for breast cancer metastases. High protein levels le

Updated on:December 28,2023

Imaging after one week on pembrolizumab may predict treatment response in advanced melanoma

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainImaging the tumors of patients with advanced melanoma receiving pembrolizumab (Keytruda) after only one week—rather tha

Updated on: May 06,2024

Imaging after one week on pembrolizumab may predict treatment response in advanced melanoma

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainImaging the tumors of patients with advanced melanoma receiving pembrolizumab (Keytruda) after only one week—rather tha

Updated on:May 06,2024

Does ejaculating often reduce your risk of prostate cancer?

by Daniel Kelly,The ConversationCredit: Pixabay/CC0 Public DomainIn terms of men's health issues, prostate cancer features high on the agenda. It's thesecond most diagnosed cancer&

Updated on: April 28,2024

Does ejaculating often reduce your risk of prostate cancer?

by Daniel Kelly,The ConversationCredit: Pixabay/CC0 Public DomainIn terms of men's health issues, prostate cancer features high on the agenda. It's thesecond most diagnosed cancer&

Updated on:April 28,2024